A patient with end-stage heart failure is experiencing considerable dyspnea.Appropriate pharmacological management of this symptom includes:
A) administration of 6 mg of midazolam ( Versed ) and initiation of a continuous midazolam infusion.
B) administration of morphine, 5 mg IV bolus, and initiation of a continuous morphine infusion.
C) hourly increases of the midazolam ( Versed ) infusion by 100% dose increments.
D) hourly increases of the morphine infusion by 100% dose increments.

Question

Quizplus · Accepted Answer

Morphine is an excellent agent to control the symptom of dyspnea.A 5-mg IV bolus and initiation of a morphine drip is an appropriate initial intervention to control dyspnea.Initial dosing of midazolam should be 2 to 4 mg,and more is indicated for anxiety.The morphine dose should be titrated incrementally by 50% dose increases.Midazolam is indicated for management of dyspnea and is titrated incrementally by 50% dose increases.

A Patient with End-Stage Heart Failure Is Experiencing Considerable Dyspnea